Sanford Cancer Center

Sanford USD Medical Center, Sanford Cancer Center—
ICLIO Innovator Award Winner

Sioux Falls, South Dakota

Expanding Access to Immunotherapy in the Community Setting

As patient and provider interest in immuno-oncology treatment options grows, only a few are FDA-approved. To expand immunotherapy treatment access across their network of rural cancer centers, Sanford Health established a comprehensive research program that uses weekly tumor-specific video conferences and multidisciplinary molecular tumor boards to evaluate patients for clinical trial eligibility and immunotherapy treatment options. Learn how system-wide virtual conferences can serve as an important decision-making tool to expand access to immunotherapy.